A vaccine targeting mutant IDH1 induces antitumour immunity-Reference-Cited by-同舟云学术

A vaccine targeting mutant IDH1 induces antitumour immunity

Published:2014-06-25 Issue:7514 Volume:512 Page:324-327
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Schumacher Theresa,Bunse Lukas,Pusch Stefan,Sahm Felix,Wiestler Benedikt,Quandt Jasmin,Menn Oliver,Osswald Matthias,Oezen Iris,Ott Martina,Keil Melanie,Balß Jörg,Rauschenbach Katharina,Grabowska Agnieszka K.,Vogler Isabel,Diekmann Jan,Trautwein Nico,Eichmüller Stefan B.,Okun Jürgen,Stevanović Stefan,Riemer Angelika B.,Sahin Ugur,Friese Manuel A.,Beckhove Philipp,von Deimling Andreas,Wick Wolfgang,Platten Michael

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/nature13387.pdf

Reference26 articles.

1. Balss, J. et al. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 116, 597–602 (2008)

2. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008)

3. Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009)

4. Marcucci, G. et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J. Clin. Oncol. 28, 2348–2355 (2010)

5. Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009)

Cited by 607 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence;International Immunopharmacology;2024-12

2. Translational Research Platform for Malignant Central Nervous System Tumors;Neurologia medico-chirurgica;2024-09-15

3. Advances in the treatment of IDH-mutant gliomas;Current Opinion in Neurology;2024-09-12

4. Immunotherapeutic advances in glioma management: The rise of vaccine‐based approaches;CNS Neuroscience & Therapeutics;2024-08-30

5. Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective;Vaccines;2024-08-22